Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options
Shareholders of Elevance Health would probably like to forget the past six months even happened. The stock dropped 24.6% and now trades at $308.66. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Elevance Health (NYSE:ELV) and its peers.
Elevance Health and the National Association of Community Health Centers (NACHC) are proud to announce the integration of Food as Medicine (FAM) programming with primary care Community Health Centers (CHCs). This milestone - built on a shared commitment to whole health and community-centered innovation - marks a transformative step forward in addressing food/nutrition insecurity and diet-related chronic conditions through clinical integration.
In a striking display of market intervention and strategic investment, two major corporate developments are sending ripples through the financial world. The U.S. government is reportedly considering an unprecedented ownership stake in struggling chipmaker Intel (NASDAQ: INTC), signaling a direct and significant move to bolster domestic semiconductor manufacturing. Simultaneously,
Curious about the top performers within the S&P500 index in the middle of the day on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
The board of directors of Elevance Health (NYSE: ELV) announced today that Steve Collis, a highly regarded global healthcare executive, will be joining the company’s board, effective August 1. He will also serve on the board’s Audit and Finance Committees, further enhancing the board’s industry expertise and financial oversight capabilities. His addition is part of the board’s ongoing commitment and structured approach to refresh its membership in support of the company’s strategy, stakeholder needs, and the broader healthcare landscape.
July 28, 2025 — A wave of legal uncertainty has once again cast a shadow over Centene Corporation (NYSE:CNC), as shareholders grapple with the implications of a new class action lawsuit that alleges securities fraud and corporate misrepresentation. The development has sent ripples across the healthcare investment sector and raised
